Dermatological high-dose-rate beta-brachytherapy for treatment of basal and squamous cell carcinomas and extramammary Paget's disease

C Cipriani, M Desantis, T Wendler - 2016 - Soc Nuclear Med
1442 Objectives Most non-melanoma skin tumors can be easily treated with conventional
methods. However in eldery patients with large or multiple lesions satisfactory surgical …

Epidermal Radionuclide Therapy: Dermatological High-Dose-Rate Brachytherapy for the Treatment of Basal and Squamous Cell Carcinoma

C Cipriani, AF Sedda - Therapeutic Nuclear Medicine, 2012 - Springer
Non-melanocytic skin cancer (NMSC) is the most frequent malignancy among populations of
European origin, and in some countries it accounts for about half of all tumours. In the …

[PDF][PDF] Personalized high-dose-rate brachytherapy with non-sealed rhenium-188 in non-melanoma skin cancer

C Cipriani, B Frisch, K Scheidhauer, M Desantis - Int J Nucl Med Res, 2017 - core.ac.uk
Objectives: Most non-melanoma skin tumors are treated with conventional methods, being
the most common surgery. However, satisfactory surgical treatment can be very challenging …

Clinical implementation of a new electronic brachytherapy system for skin brachytherapy

O Pons-Llanas, R Ballester-Sánchez… - Journal of …, 2015 - termedia.pl
Purpose Basal cell carcinoma (BCC) is a common cancer in humans. It is a skin cancer
caused by exposure to ultraviolet radiation and the incidence increases with age [1]. It is a …

Radionuclide therapy for skin malignancies

AEH Cho, MG Lee, JD Lee - Therapeutic Nuclear Medicine, 2012 - Springer
Skin cancer is the most common human malignancy. Basal cell carcinoma (BCC) and
squamous cell carcinoma (SCC) constitute approximately over 95%(80 and 16 …

Role of High-Dose-Rate Brachytherapy in the Treatment of Skin Carcinomas at the High-Risk “Mask Areas” of the Face

M Ghaly, J Li, K Satchwill, L Graham, D Serviss… - …, 2010 - brachyjournal.com
Purpose: To present treatment results of patients with superficial skin cancer at the mask
areas of the face. Lesions in these areas are at higher risk for recurrence due to surface …

Two years results of electronic brachytherapy for basal cell carcinoma

R Ballester-Sánchez, O Pons-Llanas… - Journal of …, 2017 - termedia.pl
Purpose: The use of radiation therapy (RT) for non-melanoma skin cancer (NMSC) has been
changing throughout the last century. Over the last decades, the use of radiotherapy has …

Dermo Beta Brachytherapy with 188Re in extramammary Paget's disease.

AM Carrozzo, C Cipriani, P Donati… - Giornale Italiano di …, 2014 - europepmc.org
Aim Extramammary Paget's disease (EMPD) is a rare neoplastic pathology involving the
vulva, scrotum, and perianal areas, and it is characterized by a slow and insidious course …

Dermatological high‐dose‐rate brachytherapy for the treatment of basal and squamous cell carcinoma

AF Sedda, G Rossi, C Cipriani… - Clinical and …, 2008 - academic.oup.com
Background. Basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) are among
the most common cancers in humans. Various therapies are currently being used to treat …

Advances in skin brachytherapy: cosmesis and function preservation

A Rembielak, G Mansy, EA Barnes, J Licher, N Tselis - Clinical Oncology, 2023 - Elsevier
Skin brachytherapy represents an excellent alternative treatment for patients with non-
melanoma skin cancers. It offers superior conformity of dose distribution with rapid dose fall …